NuCana
NCNA | NASDAQ
$0.86
-$0.07 (-7.79%)
At close: Nov 16, 2026, 4:00 PM ET
$0.87
+$0.01 (+1.16%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-7.79%
(1D)No price chart data available for 1D timeframe.
Rating
23.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #960/1021 (Top 94%)
Key Statistics
Market Data
Market Cap $5.24M
1D Range
0.86 0.94
52W Range
0.86 4.43
Valuation (TTM)
PE -0.20
PB 0.20
EV/EBITDA 1.11
Valuation (NTM)
Forward PE N/A
Forward PEG -0.75
Price Target $0.00
Cash Flow
FCF Yield -198.4%
SBC Adj. FCF Yield -268.1%
SBC Impact -35.1%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 141.9% |
52.0%
FCF 3Y | 5Y 18.5% |
30.9%
Returns
ROA -44.9%
ROE -51.0%
ROIC -64.5%
Financial Health
Net Cash
£18.43M ($24.45M)
Current Ratio 5.15
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platfo...
Sector Healthcare
Industry Biotechnology
Employees 11
IPO Date Sep 28, 2017
Website www.nucana.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove NCNA